Back to 
MetLife Investment Management, LLC
MetLife Investment Management, LLC
OCDXShowing 0 of 6 quarters
Position history for MetLife Investment Management, LLC's holdings in ORTHO CLINICAL DIAGNOSTICS H
As of its Q1 2022 13F, MetLife Investment Management held 66,635 shares of OCDX (Ortho Clinical Diagnostics), worth $1.2M. MetLife Investment Management's 13F filings listed OCDX from Q1 2021 to Q1 2022, 5 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of OCDX: Carlyle Group Inc.